Facebook Pixel Code
Cancer clinic space
Garron Family Cancer Centre

PERCC

Over 80 per cent of children with cancer live in low- and middle-income countries (LMICs); their cure rates lag far behind those of children in high-income countries (HICs).

 National Childhood Cancer Strategies hold the potential to increase childhood cancer cure rates across large LMIC populations, but are in place in only a handful of LMIC. 

Barriers to adoption include a lack of health policy, health economics and implementation research relevant to LMIC paediatric oncology. Through a collaborative approach PERCC will support LMICs in an effort to overcome these barriers.

PERCC is sponsored by the Garron Family Cancer Centre and the Centre for Global Child Health.


PERCC Goals:

  • Conduct health policy and health economics research relevant to the care of children with cancer in LMICs
  • Use the results of such research to inform advocacy and policy efforts at various national and international levels

PERCC News:

November 2019
PERCC members were well represented at the 12th International Conference on Cancer in Africa (AORTIC 2019) in Maputo, Mozambique!

Dr. Denburg (Second from right) presented on comparative childhood cancer policies across five countries.

Rhonda Boateng presented on access to childhood cancer drugs in Ghana

 

Dr. Gupta presented preliminary findings on the cost and cost-effectiveness of childhood cancer treatment in Sub-Saharan Africa.

September 2019
On September 26th, 2019, the ACCESS initiative, co-led by Dr. Avram Denburg, hosted its Inaugural Regional Stakeholder Meeting in Nairobi, Kenya.

Over 44 representatives from the global cancer community, East African Community (EAC), governmental, non-governmental, bi-lateral, clinical, local pharmaceutical, and academic institutions convened for a one-day event to gather insight from key stakeholders on existing challenges and solutions related to childhood cancer drug access in East Africa, and to identify priority, context-specific research questions and approaches under the umbrella of ACCESS.
A variety of key areas emerged as policy and programming priorities:
• strengthening opportunities for evidence-based forecasting and centralized procurement procedures;
• Research data needed for drug forecasting, building cancer and hospital-based registries and in capturing health system structure and dynamics; and
• Strengthening opportunities for enhanced collaborative engagement to harmonize clinical practice procedures.
Over the next year, the ACCESS core team will be actively engaged in a program of research to inform the aforementioned priority areas.  For more details on this project, please refer to the ACCESS website.

Visit our Past News section for past updates from PERCC.